Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. STKE, 4 March 2003
Vol. 2003, Issue 172, p. re5
[DOI: 10.1126/stke.2003.172.re5]
REVIEWS
The Many Forks in FOXO's Road
Hien Tran,
Anne Brunet,
Eric C. Griffith, and
Michael E. Greenberg*
Department of Neurobiology, Division of Neuroscience, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
The FOXO family of transcription factors constitute an evolutionarily conserved subgroup within the larger family known as winged helix or Forkhead transcriptional regulators. Building upon work in the nematode, researchers have uncovered a role for these proteins in a diverse set of cellular responses that include glucose metabolism, stress response, cell cycle regulation, and apoptosis. At the organismal level, FOXO transcription factors are believed to function in various pathological processes ranging from cancer and diabetes to organismal aging. A number of studies have also shed light on the signaling pathways that regulate FOXO activity in response to external stimuli and have identified multiple FOXO target genes that mediate this varied set of biological responses.
Nancy R. Gough, Lisa D. Chong, Elizabeth M. Adler, and L. Bryan Ray (4 March 2003) Sci. STKE2003 (172), eg4.
[DOI: 10.1126/stke.2003.172.eg4] |Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Foxo3-/- mice demonstrate reduced numbers of pre-B and recirculating B cells but normal splenic B cell sub-population distribution.
R. M. Hinman, W. A. Nichols, T. M. Diaz, T. D. Gallardo, D. H. Castrillon, and A. B. Satterthwaite (2009)
Int. Immunol.
21, 831-842
|Abstract »|Full Text »|PDF »
O-GlcNAc Regulates FoxO Activation in Response to Glucose.
M. P. Housley, J. T. Rodgers, N. D. Udeshi, T. J. Kelly, J. Shabanowitz, D. F. Hunt, P. Puigserver, and G. W. Hart (2008)
J. Biol. Chem.
283, 16283-16292
|Abstract »|Full Text »|PDF »
EPO receptor circuits for primary erythroblast survival.
P. Sathyanarayana, A. Dev, J. Fang, E. Houde, O. Bogacheva, O. Bogachev, M. Menon, S. Browne, A. Pradeep, C. Emerson, et al. (2008)
Blood
111, 5390-5399
|Abstract »|Full Text »|PDF »
B Cell Receptor Signaling Down-Regulates Forkhead Box Transcription Factor Class O 1 mRNA Expression via Phosphatidylinositol 3-Kinase and Bruton's Tyrosine Kinase.
R. M. Hinman, J. N. Bushanam, W. A. Nichols, and A. B. Satterthwaite (2007)
J. Immunol.
178, 740-747
|Abstract »|Full Text »|PDF »
Akt-dependent Expression of NAIP-1 Protects Neurons against Amyloid-{beta} Toxicity.
S. Lesne, C. Gabriel, D. A. Nelson, E. White, E. T. MacKenzie, D. Vivien, and A. Buisson (2005)
J. Biol. Chem.
280, 24941-24947
|Abstract »|Full Text »|PDF »
Molecular and Cellular Determinants of Skeletal Muscle Atrophy and Hypertrophy.
Identification of Transcription Factor Binding Sites Upstream of Human Genes Regulated by the Phosphatidylinositol 3-Kinase and MEK/ERK Signaling Pathways.
J. W. Tullai, M. E. Schaffer, S. Mullenbrock, S. Kasif, and G. M. Cooper (2004)
J. Biol. Chem.
279, 20167-20177
|Abstract »|Full Text »|PDF »